IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Ridgeback Capital Investments L.P.

Q4 2015 Holdings

Filed 2016-02-16 | 4 holdings | $23.2K | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Cara Therapeutics, Inc.(CARAEUR)COM140755109$10.5K622,14045.1%
Applied Genetic Technologies Inc.(2GT)COM03820J100$5.0K246,00521.6%
Trillium Therapeutics Inc.COM89620X506$4.7K370,53720.1%
Oncosec Medical Inc.COM68234L207$3.1K1,292,61413.2%